Inside Trade: Kevin Cornwell Sold 150 Shares of Utah Medical Products, Inc. (UTMD); Varian Medical Systems Has 1.02 Sentiment

As discovered in an electronic document that’s filled with the Washington-based SEC on February 20, 2018, Kevin Cornwell, Chairman – CEO – Secretary of Utah Medical Products Inc and a well informed man, made a sale of 150 shares of the company for $13,669 U.S Dollars at average stock price per share of $91.1. Kevin Cornwell holds precisely 6.49% of Utah Medical Products Inc’s total market capitalization or 241,621 shares.

Varian Medical Systems, Inc. designs, makes, sells, and services medical devices and software products for treating cancer and other medical conditions worldwide. The company has market cap of $10.97 billion. It operates through two divisions, Oncology Systems and Imaging Components. It has a 90.29 P/E ratio. The Oncology Systems segment provides hardware and software products for treating cancer with radiotherapy, fixed field intensity-modulated radiation therapy, image-guided radiation therapy, volumetric modulated arc therapy, stereotactic radiosurgery, stereotactic body radiotherapy, and brachytherapy.

Lafleur & Godfrey Llc holds 3.47% of its portfolio in Varian Medical Systems, Inc. for 132,489 shares. Capital Counsel Llc Ny owns 325,993 shares or 2.92% of their US portfolio. Moreover, Fairpointe Capital Llc has 2.53% invested in the company for 1.28 million shares. The Alberta – Canada-based Qv Investors Inc. has invested 2.13% in the stock. Alecta Pensionsforsakring Omsesidigt, a Sweden-based fund reported 2.46 million shares.

The stock decreased 0.90% or $1.09 during the last trading session, reaching $120.17. About 809,374 shares traded or 1.16% up from the average. Varian Medical Systems, Inc. (VAR) has risen 29.46% since February 20, 2017 and is uptrending. It has outperformed by 12.76% the S&P500.

Since January 1, 0001, it had 0 insider purchases, and 20 insider sales for $22.12 million activity.

Ratings analysis reveals 50% of Varian Medical’s analysts are positive. Out of 2 Wall Street analysts rating Varian Medical, 1 give it “Buy”, 0 “Sell” rating, while 1 recommend “Hold”. The lowest target is $93.0 while the high is $98.0. The stock’s average target of $95.50 is -20.53% below today’s ($120.17) share price. VAR was included in 2 notes of analysts from January 23, 2017. The firm has “Sector Perform” rating by RBC Capital Markets given on Monday, January 23. Barrington Research maintained Varian Medical Systems, Inc. (NYSE:VAR) on Friday, January 27 with “Outperform” rating.

Utah Medical Products, Inc. develops, makes, and distributes medical devices for the healthcare industry worldwide. The company has market cap of $333.37 million. It provides fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD, an infant respiratory hood; and DELTRAN PLUS, a blood pressure monitoring system. It has a 39.37 P/E ratio. The firm also offers umbilical vessel catheters; DIALY-NATE, a disposable peritoneal dialysis set; PALA-NATE, a silicone oral protection device; URI-CATH, a urinary drainage system; and MYELO-NATE, a lumbar sampling kit.

Since February 2, 2018, it had 0 insider purchases, and 3 insider sales for $603,579 activity. $464,447 worth of stock was sold by HOYER ERNST G on Thursday, February 15.

The stock decreased 1.32% or $1.2 during the last trading session, reaching $89.6. About 15,937 shares traded or 27.60% up from the average. Utah Medical Products, Inc. (NASDAQ:UTMD) has declined 0.94% since February 21, 2017 and is downtrending. It has underperformed by 17.64% the S&P500.

Investors sentiment increased to 1.57 in 2017 Q3. Its up 0.19, from 1.38 in 2017Q2. It improved, as 3 investors sold Utah Medical Products, Inc. shares while 20 reduced holdings. 6 funds opened positions while 30 raised stakes. 2.41 million shares or 0.13% more from 2.40 million shares in 2017Q2 were reported. Ameritas Inv Ptnrs owns 296 shares for 0% of their portfolio. Clean Yield Grp has 48,149 shares. Denali Ltd Liability Co holds 64 shares. Seizert Prns Limited Com invested in 6,512 shares. Bancorporation Of Mellon Corp invested in 0% or 28,308 shares. Barclays Public Limited Company holds 679 shares. Schwab Charles Inv Mgmt invested in 7,700 shares or 0% of the stock. Ancora Ltd Liability Corporation holds 0.26% or 60,881 shares. Sei Invests Com holds 0% or 3,287 shares. Moreover, First Quadrant L P Ca has 0.01% invested in Utah Medical Products, Inc. (NASDAQ:UTMD). Citigroup Inc owns 3,635 shares for 0% of their portfolio. Blackrock Inc owns 158,611 shares. Morgan Stanley invested 0% in Utah Medical Products, Inc. (NASDAQ:UTMD). Cardinal reported 9,962 shares or 0.23% of all its holdings. Martingale Asset Mgmt L P holds 0.02% or 17,201 shares in its portfolio.